-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

723.P1.56 723. Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence: Poster I

Clinical Allogeneic and Autologous Transplantation: Late Complications and Approaches to Disease Recurrence Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 5, 2015: 5:30 PM-7:30 PM
Hall A, Level 2 (Orange County Convention Center)

Dana L Shanis, MD1*, Prathima Anandi, MD2*, Caitlin Grant1*, Priyanka A Pophali, MD3, Eleftheria Koklanaris4*, Bipin N. Savani, MD5, Austin John Barrett, MD, FRCP, FRCPath2, Minoo Battiwalla, MD, MS2 and Pamela Stratton, MD1*

1NICHD, NIH, Bethesda, MD
2Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
3Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
4NHLBI, NIH, Bethesda, MD
5Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN

Jeffrey S. Miller, MD1, Sarah Cooley, MD1, Shernan Holtan1*, Mukta Arora, MD1, Celalettin Ustun, MD1, Emily Jeng2*, Hing C. Wong2*, Michael R. Verneris, MD1, John E. Wagner, MD1, Daniel J. Weisdorf, MD1, Bruce R. Blazar, MD1, Todd A Fehniger, MD, PhD3 and Rizwan Romee, MD3

1Adult and Pediatric Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN
2Altor Bioscience Corporation, Miramar, FL
3Division of Oncology, Department of Medicine, Washington University, St. Louis, MO

Donal McLornan, MD PhD1*, Richard Szydlo, PhD2*, Anja van Biezen3*, Linda Koster3*, Evgeny Klyuchnikov4*, Andrea Bacigalupo, MD5, Michael Schleuning6, Jurgen Finke, M.D.7, Antonin Vitek, MD PhD8*, Andrew Peniket, MD9*, Dietrich W. Beelen, MD10, Charles Craddock, BM, FRCP, FRCPath11, Jane F. Apperley, MD12, Wolfgang Bethge, MD13*, Didier Blaise, MD, PhD14, Dietger Niederwieser, MD15, Liisa Volin, MD, PhD16, Peter Dreger, MD17, Mauricette Michallet, MD, PhD18, Arnon Nagler, MD, MSc19, Renate Arnold, MD20, Eduardo Olavarria, MD21* and Nicolaus Kroeger, MD22

1Department of Haematological Medicine, King’s College Hospital NHS Foundation Trust, London, United Kingdom
2Centre for Haematology, Imperial College London, London, United Kingdom
3EBMT Data Office, University Medical Center, Leiden, Netherlands
4University Medical Centre Eppendorf, Hamburg, Germany
5Second Division of Hematology and Bone Marrow Transplantation,IRCCS AOU San Martino-IST, IRCCS San Martino-IST, Genoa, Italy
6Centre for hematopoietic cell transplantation, German Diagnostic Clinic, Wiesbaden, Germany
7Hematology, Oncology and Stem Cell Transplantation, University of Freiburg, Freiburg, Germany
8Institute of Hematology and Blood Transfusion, Prague, Czech Republic
9Department of Haematology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
10Department of Stem Cell Transplantation, University Medical Center Essen, Essen, Germany
11Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom
12Haematology Department, Hammersmith Hospital (Imperial College Healthcare NHS Trust), London, United Kingdom
13Department of Hematology and Oncology, University of Tuebingen, Tuebingen, Germany
14Programme de Transplantation et Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
15Hematology and Oncology, University of Leipzig, Leipzig, Germany
16Stem Cell Transplantation Unit, Helsinki University Hospital, Comprehensive Cancer Center, Helsinki, Finland
17Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
18Department of Hematology, Centre Hospitalier Lyon-Sud, Lyon, France
19Hematology Division, Chaim Sheba Medical Center and Tel Aviv University, Tel-Hashomer, Ramat-Gan, Israel
20Department of Stem Cell Transplantation, Charité University Medicine Berlin, Berlin, Germany
21Centre for Haematology, Imperial College Hammersmith Hospital, London, United Kingdom
22Department for Stem Cell Transplantation, University of Hamburg, Hamburg, Germany

Boris Fehse, PhD1*, Anita Badbaran1*, Maximilian Christopeit, M.D.1*, Tim Aranyossy2*, Francis Ayuk, M.D.2*, Christine Wolschke, M.D.1* and Nicolaus Kroeger2

1Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
2University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Melhem Solh, MD1, Katelin Connor1*, Xu Zhang, PhD2*, Stacey Brown, B.A.1*, Lawrence E. Morris, MD1, H. Kent Holland, MD1, Asad Bashey, MD, PhD1 and Scott R. Solomon, MD1

1The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
2Department of Mathematics and Statistics, Georgia State University, Atlanta, GA

Robert Chen1, Joycelynne Palmer, PhD2*, Leona Holmberg3, Jessica Alluin4*, Pritsana Chomchan, PhD5*, Leslie L. Popplewell, MD4, Tanya Siddiqi, MD1, Sandra H. Thomas, PhD6, Kathryn Irenze7*, Auayporn P. Nademanee, MD8, Ricardo Spielberger, MD4, John J Rossi4*, Steven T. Rosen, MD9, Larry W. Kwak, MD10* and Stephen J. Forman, MD6

1City of Hope National Medical Center, Duarte, CA
2Information Sciences, City of Hope, Duarte, CA
3Fred Hutchinson Cancer Rsch. Ctr., Seattle, WA
4City of Hope, Duarte, CA
5Molecular biology, City of Hope, Duarte, CA
6Hematology & Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
7hematology, City of Hope, Duarte, CA
8Department of Hematology and HCT, City of Hope, Duarte, CA
9Division of Hematopoietic Stem Cell and Leukemia Research of Beckman Research Institute, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA
10Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA

Nancy M. Hardy, MD1,2, Deborah Citrin, MD3*, Frances T. Hakim, PhD2*, Daniele N. Avila, CRNP4*, Bazetta Blacklock-Schuver, RN4*, Stephanie Cotton, RN2*, Monica Cho2*, Daniel H. Fowler, MD4*, Juan C. Gea-Banacloche, MD4*, Noa G. Holtzman, MD5*, Karen A. Kurdziel, MD6*, Sarfraz Memon, MD4*, Steven Z. Pavletic, MD4, Stefania Pittaluga, MD, PhD7, Jeremy J. Rose, BA4*, Claude Sportes, MD2,8*, Jennifer S. Wilder, RN9*, Ronald E. Gress, MD2 and Michael R. Bishop, MD2,10*

1Department of Medicine and Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD
2Experimental Transplantation & Immunology Branch, Center for Cancer Research, National Institutes of Health, National Cancer Institute, Bethesda, MD
3Radiation Oncology Branch, National Cancer Institute, Center for Cancer Research, Bethesda, MD
4Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
5University of Maryland School of Medicine, Baltimore, MD
6Molecular Imaging Program, Center for Cancer Research, National Institutes of Health, National Cancer Institute, Bethesda, MD
7Laboratory of Pathology, National Cancer Institute, Bethesda, MD
8GRU Cancer Center, Georgia Regents University, Augusta, GA
9Frederick National Laboratory for Cancer Research, Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., Frederick, MD
10Hematopoietic Stem Cell Transplantation Program, University of Chicago School of Medicine, Chicago, IL

Kareem Jamani, MD1, Andrew Daly, MD, FRCPC2 and Jan Storek, MD, PhD2

1Alberta Blood and Marrow Transplant Program, University of Calgary, Calgary, AB, Canada
2University of Calgary, Calgary, AB, Canada

Honghua Li1*, Wenrong Huang1*, Chunji Gao2, Liping Dou1*, Fei Li1*, Quanshun Wang1*, Lili Wang1*, Li Yu1* and Dai-Hong Liu1

1Department of Hematology, Chinese PLA General Hospital, Beijing, China
2Dept. of Hematology, Chinese PLA General Hospital, Beijing, China

Aby Abraham, MD, DM1*, Eunice Sindhuvi, PhD2*, Anu Korula, MD, DM1*, Fouzia NA, Dip NB, DM,1*, Alok Srivastava, MD, FRACP1, Biju George, DM1 and Vikram Mathews, DM1

1Department of Haematology, Christian Medical College, Vellore, India
2Department of Hematology, Christian Medical College, Vellore,India, Vellore, India

David J. Chung, MD, PhD1,2,3, Katherine B. Pronschinske4*, Justin A. Shyer4*, Sneh Sharma4*, Samantha Leung4*, Shane A. Curran4*, Alexander M. Lesokhin, MD2,5, Sean Devlin, PhD6*, Sergio A. Giralt, MD7,8 and James W. Young, MD2,3,9

1Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Weill Cornell Medical College, New York, NY
3The Rockefeller University, New York, NY
4Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
7Weill Cornell Medical College, Cornell University, New York, NY
8Department of Medicine, Adult Bone Marrow Transplantation Services, Memorial Sloan Kettering Cancer Center, New York, NY
9Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

Melhem Solh, MD1, Xu Zhang, PhD2*, Stacey Brown, B.A.1*, Lawrence E. Morris, MD1, H. Kent Holland, MD1, Scott R. Solomon, MD1 and Asad Bashey, MD, PhD1

1The Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
2Department of Mathematics and Statistics, Georgia State University, Atlanta, GA

Elena Zamagni1*, Giuseppe Bandini2*, Annalisa Pezzi, PhD1*, Paola Tacchetti2*, Ilaria Rizzello2*, Lucia Pantani2*, Mario Arpinati, MD, PhD2, Beatrice A Zannetti, MD1*, Serena Rocchi2*, Mariarosaria Sessa2*, Annamaria Brioli2*, Katia Mancuso2*, Carolina Terragna, PhD1*, Nicoletta Testoni3*, Francesca Bonifazi2* and Michele Cavo, MD4*

1DIMES - Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology, University of Bologna, Bologna, Italy
2Università di Bologna, Seragnoli Institute of Hematology, Bologna, Italy
3University of Bologna, Bologna, Italy
4Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy

Carter Biewen, BA1*, Angela R Smith, MD, MS2, Jakub Tolar, M.D., Ph.D.2 and Weston P Miller IV, MD2

1School of Medicine, University of Minnesota, Minneapolis, MN
2Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN

Xiaosu Zhao1*, Yazhen Qin2,3*, Yanrong Liu1*, Lanping Xu1*, Xiao-Hui Zhang3,4*, Xiaojun Huang5 and Yingjun Chang5*

1Peking University Institute of Hematology, Beijing, China
2Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
3Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
4Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
5Peking University People’s Hospital & Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China

*signifies non-member of ASH